Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 January 2001

Pseudomembranous colitis after eradication of Helicobacter pylori infection with a triple therapy

Igor Alexander Harsch, Eckhart Georg Hahn, Peter Christopher Konturek

Med Sci Monit 2001; 7(4): CS751-754 :: ID: 421074

Abstract

BACKGROUND: H.pylori (H.p.) infection of the gastric mucosa is causallyrelated to chronic gastritis, peptic ulcer disease, MALT-lymphoma and gastric cancer. There is also anevidence for a link between the H.p.-infection and non-ulcer dyspepsia and even extragastric diseases.The number of patients treated against H.p. infection is expanding. Although in the last years the PPI-basedtriple therapies have been considered to be effective and safe, in some patients, however, severe side-effectsmay occur.
CASE REPORT: We report on a 86 year old female patient, who received a one-week triple eradicationtherapy (metronidazole 3x400 mg/die, clarithromycin 2x250 mg/die and omeprazole 2x20 mg/die) becauseof non-ulcer dyspepsia. A few days after the eradication treatment, she developed profuse watery andbloody diarrhea and abdominal pain with distention. In stool specimens Clostridium difficile toxin wasdetected. A colonoscopy showed typical features of antibiotic associated pseudomembranous colitis. Untilnow, only few reports concerning this complication have been published and the frequency of the complicationin patients eradicated for H.p. is unknown. The potential risk factors to develop this condition havenot been clarified. Since the complication may be potentially lethal, this severe side-effect of theusually well-tolerated triple-therapy has to be considered in patients suffering from profuse diarrheaand abdominal pain after eradication therapy.

Keywords: Helicobacter pylori, pseudomembranous colitis, clostridium difficile colitis, eradication

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750